Tempus AI, Inc. TEM Business Segments
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| Revenue by Product | ||||
| AI Applications | $20.1M+63.4% | $12.3M+141% | $5.1M— | |
| Clinical Order | $884.5M+116% | $409.4M+24.7% | $328.4M+109% | |
| Insights Product | $257.7M+38.0% | $186.8M+58.8% | $117.6M+33.0% | |
| Trials Product | $38.5M-9.4% | $42.5M-6.8% | $45.6M+46.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Tempus AI, Inc. break its business down?
- Tempus AI, Inc. (TEM) reports revenue by product across 6 parts — AI Applications, Clinical Order, Genomics Product, Insights Product and Next Product. Each is extracted from the segment footnotes and tracked over time.
- Where does Tempus AI, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Tempus AI, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
